当疫情碰撞：2019 年冠状病毒病（COVID-19）和阿片类药物危机。
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis.
机构信息
VA Connecticut Healthcare System, West Haven, Connecticut, and Yale Program in Addiction Medicine and Yale School of Medicine, New Haven, Connecticut (W.C.B.).
Yale Program in Addiction Medicine and Yale School of Medicine, New Haven, Connecticut (D.A.F.).
出版信息
Ann Intern Med. 2020 Jul 7;173(1):59-60. doi: 10.7326/M20-1210. Epub 2020 Apr 2.
Abstract
COVID-19 could cause infection in persons with opioid use disorder, increase opioid overdose rates, reverse system-level gains in expanding access to medication for opioid use disorder, halt critical research, and prevent exacting legal reparations against opioid manufacturers. The authors call for urgent action to counteract these risks.
摘要
COVID-19 可能导致阿片类药物使用障碍患者感染，增加阿片类药物过量率，使扩大阿片类药物使用障碍药物治疗的系统层面取得的进展出现逆转，阻碍关键研究，并阻止对阿片类药物制造商进行严格的法律赔偿。作者呼吁采取紧急行动来应对这些风险。
相似文献
1
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis.当疫情碰撞：2019 年冠状病毒病（COVID-19）和阿片类药物危机。
Ann Intern Med. 2020 Jul 7;173(1):59-60. doi: 10.7326/M20-1210. Epub 2020 Apr 2.
2
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19.大流行中的疫情：阿片类药物使用障碍和 COVID-19。
Ann Intern Med. 2020 Jul 7;173(1):57-58. doi: 10.7326/M20-1141. Epub 2020 Apr 2.
3
Update: COVID-19 Upends Progress on Opioid Crisis.更新：新冠疫情打乱阿片类药物危机的应对进程。
Am J Nurs. 2020 Oct;120(10):16. doi: 10.1097/01.NAJ.0000718568.58987.33.
4
Collision of the COVID-19 and Addiction Epidemics.新冠肺炎与成瘾流行病的碰撞。
Ann Intern Med. 2020 Jul 7;173(1):61-62. doi: 10.7326/M20-1212. Epub 2020 Apr 2.
5
An overdose surge will compound the COVID-19 pandemic if urgent action is not taken.如果不采取紧急行动，药物过量潮将使 COVID-19 大流行更加严重。
Nat Med. 2020 Jun;26(6):819-820. doi: 10.1038/s41591-020-0898-0.
6
Widespread Postponement of Functional Urology Cases During the COVID-19 Pandemic: Rationale, Potential Pitfalls, and Future Consequences.新冠疫情期间功能性泌尿外科病例的广泛推迟：理由、潜在陷阱及未来后果
Eur Urol. 2020 Jul;78(1):4-5. doi: 10.1016/j.eururo.2020.04.031. Epub 2020 Apr 23.
7
Changes in the work mode of cardiologists during the COVID-19 epidemic in Wuhan.武汉新冠疫情期间心脏病专家工作模式的变化
Eur Heart J. 2020 Aug 1;41(29):2729-2730. doi: 10.1093/eurheartj/ehaa424.
8
Distancing? But still I-care: Tele-ophthalmology during COVID-19 era.保持距离？但我仍关心：新冠疫情时代的远程眼科
Indian J Ophthalmol. 2020 Jul;68(7):1243-1244. doi: 10.4103/ijo.IJO_1875_20.
9
The Time Is Now: A Guide to Sustainable Telemedicine During COVID-19 and Beyond.就是现在：新冠疫情期间及之后的可持续远程医疗指南。
Am J Gastroenterol. 2020 Sep;115(9):1371-1375. doi: 10.14309/ajg.0000000000000767.
10
Telemedicine in gastroenterology in the wake of COVID-19.COVID-19 疫情下的胃肠病学远程医疗
Expert Rev Gastroenterol Hepatol. 2020 Nov;14(11):1013-1015. doi: 10.1080/17474124.2020.1806056. Epub 2020 Aug 18.
引用本文的文献
1
Opioid Treatment Programs and Risks for COVID-19 Infections, Emergency Visits, and Hospitalizations.阿片类药物治疗项目与感染新型冠状病毒、急诊就诊及住院的风险
J Gen Intern Med. 2025 Feb 25. doi: 10.1007/s11606-025-09444-3.
2
A Narrative Review of Old and Emerging Treatment Modalities for Substance Use Disorders.物质使用障碍的传统与新兴治疗方式叙事综述
Cureus. 2024 Dec 9;16(12):e75395. doi: 10.7759/cureus.75395. eCollection 2024 Dec.
3
Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality.疫情演变：了解美国的阿片类药物流行情况以及 COVID-19 大流行对阿片类药物相关死亡率的影响。
PLoS One. 2024 Jul 9;19(7):e0306395. doi: 10.1371/journal.pone.0306395. eCollection 2024.
4
Implementation, intervention, and downstream costs for implementation of a multidisciplinary complex pain clinic in the Veterans Health Administration.退伍军人健康管理局实施多学科复杂疼痛诊所的实施、干预和下游实施成本。
Health Serv Res. 2024 Dec;59 Suppl 2(Suppl 2):e14345. doi: 10.1111/1475-6773.14345. Epub 2024 Jul 2.
5
A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic.加拿大阿片类药物过量危机与新冠疫情并发期间阿片类药物过量死亡的动态模型
Int J Environ Res Public Health. 2024 Apr 4;21(4):442. doi: 10.3390/ijerph21040442.
6
Primary Care Providers' Experiences Treating Opioid Use Disorder Using Telehealth in the Height of the COVID-19 Pandemic.初级保健提供者在 COVID-19 大流行期间使用远程医疗治疗阿片类药物使用障碍的经验。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241246359. doi: 10.1177/21501319241246359.
7
The Relationship Between Workplace Drug Policies, Opioid Misuse, and Psychological Distress: Evidence From the 2020 National Survey on Drug Use and Health.工作场所毒品政策、阿片类药物滥用与心理困扰之间的关系：来自 2020 年全国毒品使用与健康调查的证据。
New Solut. 2024 May;34(1):22-37. doi: 10.1177/10482911241231523. Epub 2024 Feb 8.
8
Identifying Patient Characteristics Associated With Opioid Use to Inform Surgical Pain Management.确定与阿片类药物使用相关的患者特征，为手术疼痛管理提供参考。
Ann Surg Open. 2023 Nov 14;4(4):e355. doi: 10.1097/AS9.0000000000000355. eCollection 2023 Dec.
9
Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality.丁丙诺啡、美沙酮及物质使用对新型冠状病毒肺炎发病率和死亡率的影响
medRxiv. 2023 Nov 27:2023.11.24.23298995. doi: 10.1101/2023.11.24.23298995.
10
Physician perspectives on chronic pain management: barriers and the use of eHealth in the COVID-19 era.医生对慢性疼痛管理的看法：COVID-19 时代的障碍和电子健康的使用。
BMC Health Serv Res. 2023 Oct 20;23(1):1131. doi: 10.1186/s12913-023-10157-8.
本文引用的文献
1
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.从高剂量、长期阿片类药物转换为丁丙诺啡：病例系列
Ann Intern Med. 2020 Jul 7;173(1):70-71. doi: 10.7326/L19-0725. Epub 2020 Apr 7.
2
Abuses of FDA Regulatory Procedures - The Case of Suboxone.美国食品药品监督管理局监管程序的滥用——以舒倍生为例
N Engl J Med. 2020 Feb 6;382(6):496-498. doi: 10.1056/NEJMp1906680. Epub 2020 Jan 8.
Zotero 插件